CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Japan is a new market research
publication announced by Reportstack. This report is an essential source of information on and analysis of the healthcare,
regulatory and reimbursement landscape in Japan. It identifies the key
trends in the country’s healthcare market and provides insights into its
demographic, regulatory, and reimbursement landscape and healthcare
infrastructure. Most importantly, the report provides valuable insights
into the trends and segmentation of the pharmaceutical and medical
device markets. It uses data and information sourced from proprietary
databases, secondary research, and in-house analysis by team members.
In 2008, Japan’s pharmaceutical market was worth $64.2 billion. It is projected to reach $79.8 billion in 2020, increasing at a Compound Annual Growth Rate (CAGR) of 1.8%. The medical device market was valued at $37 billion and is projected to grow at a CAGR of 6.1% to $75 billion in 2020, owing to universal health coverage, government initiatives, and an accessible healthcare system.
In 2013, Japan’s population was approximately 127.2 million, having declined at a negative CAGR of 0.02% from 2008. Its public healthcare expenditure accounted for 82.8% of total healthcare expenditure, and the government spent approximately $14 billion on pharmaceutical R&D.
Scope
The report provides information on the healthcare, regulatory, and reimbursement landscape in Japan and includes -
- An overview of the pharmaceutical and medical device markets, including market size, segmentation, and key drivers and barriers
- Profiles and SWOT analysis of the major players in the pharmaceutical market (Takeda, Otsuka, Pfizer, Astellas and Daiichi Sankyo) and medical device market (Hoya, Siemens Healthcare, Abbott, Medtronic and F. Hoffmann-La Roche)
- A review of the reimbursement and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
- Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the healthcare market
Reasons to buy
This report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving Japan’s healthcare market
- Drive revenue by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to affect Japan’s healthcare market
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
- Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for consolidation, investment, and strategic partnerships
- Identify, understand, and capitalize on the opportunities and challenges in Japan’s healthcare market
In 2008, Japan’s pharmaceutical market was worth $64.2 billion. It is projected to reach $79.8 billion in 2020, increasing at a Compound Annual Growth Rate (CAGR) of 1.8%. The medical device market was valued at $37 billion and is projected to grow at a CAGR of 6.1% to $75 billion in 2020, owing to universal health coverage, government initiatives, and an accessible healthcare system.
In 2013, Japan’s population was approximately 127.2 million, having declined at a negative CAGR of 0.02% from 2008. Its public healthcare expenditure accounted for 82.8% of total healthcare expenditure, and the government spent approximately $14 billion on pharmaceutical R&D.
Scope
The report provides information on the healthcare, regulatory, and reimbursement landscape in Japan and includes -
- An overview of the pharmaceutical and medical device markets, including market size, segmentation, and key drivers and barriers
- Profiles and SWOT analysis of the major players in the pharmaceutical market (Takeda, Otsuka, Pfizer, Astellas and Daiichi Sankyo) and medical device market (Hoya, Siemens Healthcare, Abbott, Medtronic and F. Hoffmann-La Roche)
- A review of the reimbursement and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
- Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the healthcare market
Reasons to buy
This report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving Japan’s healthcare market
- Drive revenue by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to affect Japan’s healthcare market
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
- Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for consolidation, investment, and strategic partnerships
- Identify, understand, and capitalize on the opportunities and challenges in Japan’s healthcare market
To access
full report with TOC, please visit CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Japan
About
Reportstack:
Reportstack
is one of the leading distributors of market research reports in the
world today. We host more than 200,000 research products from the world's top
publication houses. These publications are distributed amongst 12 top industry
verticals and 62 sub verticals, which are then further classified into 257
business categories and 5000 micro markets. The vast selection criterion
provides granular data from the length and breadth of all these industries
delivering Reportstack members with cutting edge research products to
facilitate strategic business decisions.
Contact:
Debora
White
Manager -
Marketing
Ph:
+1-888-789-6604
Reportstack
Market Research
No comments:
Post a Comment